Sionna Therapeutics (SION) Enterprise Value (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Enterprise Value data on file, last reported at -$216.2 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 19.85% year-over-year to -$216.2 million; the trailing twelve-month figure through Mar 2026 stood at -$216.2 million (up 19.85% YoY), and the FY2025 full-year result was -$235.9 million, down 59.88% from the prior year.
• Enterprise Value grew to -$216.2 million in Q1 2026, from -$235.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$35.7 million in Q3 2024 to a low of -$269.7 million in Q1 2025.
• A 3-year average of -$171.4 million and a median of -$216.2 million in 2026 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value plunged 594.65% in 2025 and gained 19.85% in 2026, its largest moves.
• Tracing SION's Enterprise Value over 3 years: stood at -$147.5 million in 2024, then plunged by 59.88% to -$235.9 million in 2025, then advanced by 8.37% to -$216.2 million in 2026.
• Business Quant data shows SION's Enterprise Value at -$216.2 million in Q1 2026, -$235.9 million in Q4 2025, and -$248.3 million in Q3 2025.